Therascape

BIONEXT creates Therascape

Press Release from Industrie.com This entity “was born from the bioinformatics expertise of Bionext and the acquisition of the intangible assets of Rhénovia Pharma in biosimulation”. See more: Source

Continue reading

A computer model to test drugs

Press Release from Reuters A biotechnology company located in Strasbourg had announced for 2017 the launch of a digital platform capable of simulating the response of human cells in contact with a molecule in order to accelerate drug development. See more: Source

Continue reading

Bionext snags Rhenovia team, tech for cell signaling prediction subsidiary

Press Release from FierceBiotech Bionext has picked up cell signaling modeling technology and the R&D team that developed it from Rhenovia Pharma. The arrangement has spawned the creation of TheraScape, a Bionext subsidiary focused on developing a platform capable of predicting what will happen when a drug interacts with a G-protein-coupled receptor (GPCR). See more: Source

Continue reading